Consistently, CD14 mutant mice are resistant to LPS‐initiated metabolic features including obesity, diabetes, and liver fat accumulation and inflammation, indicating that metabolic endotoxemia triggers NAFLD in a CD14‐dependent approach (Cani et al, 2007). The gene discussed is CD14; the disease is diabetes mellitus.